Last reviewed · How we verify

Tetraspan, B. Braun, Melsungen, Germany

Kasr El Aini Hospital · FDA-approved active Small molecule

Tetraspan, B. Braun, Melsungen, Germany is a Synthetic colloid plasma expander Small molecule drug developed by Kasr El Aini Hospital. It is currently FDA-approved for Hypovolemia and volume replacement in surgical and trauma patients, Perioperative fluid management.

Tetraspan is a synthetic colloid plasma expander that increases and maintains intravascular volume by osmotic effect.

Tetraspan is a synthetic colloid plasma expander that increases and maintains intravascular volume by osmotic effect. Used for Hypovolemia and volume replacement in surgical and trauma patients, Perioperative fluid management.

At a glance

Generic nameTetraspan, B. Braun, Melsungen, Germany
SponsorKasr El Aini Hospital
Drug classSynthetic colloid plasma expander
ModalitySmall molecule
Therapeutic areaCritical Care / Anesthesia
PhaseFDA-approved

Mechanism of action

Tetraspan is a balanced hydroxyethyl starch (HES) solution designed to restore and maintain circulating blood volume in hypovolemic patients. It works through osmotic pressure to draw and retain fluid in the intravascular space, thereby improving tissue perfusion and oxygen delivery. The balanced electrolyte formulation aims to minimize electrolyte disturbances compared to older HES formulations.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tetraspan, B. Braun, Melsungen, Germany

What is Tetraspan, B. Braun, Melsungen, Germany?

Tetraspan, B. Braun, Melsungen, Germany is a Synthetic colloid plasma expander drug developed by Kasr El Aini Hospital, indicated for Hypovolemia and volume replacement in surgical and trauma patients, Perioperative fluid management.

How does Tetraspan, B. Braun, Melsungen, Germany work?

Tetraspan is a synthetic colloid plasma expander that increases and maintains intravascular volume by osmotic effect.

What is Tetraspan, B. Braun, Melsungen, Germany used for?

Tetraspan, B. Braun, Melsungen, Germany is indicated for Hypovolemia and volume replacement in surgical and trauma patients, Perioperative fluid management.

Who makes Tetraspan, B. Braun, Melsungen, Germany?

Tetraspan, B. Braun, Melsungen, Germany is developed and marketed by Kasr El Aini Hospital (see full Kasr El Aini Hospital pipeline at /company/kasr-el-aini-hospital).

What drug class is Tetraspan, B. Braun, Melsungen, Germany in?

Tetraspan, B. Braun, Melsungen, Germany belongs to the Synthetic colloid plasma expander class. See all Synthetic colloid plasma expander drugs at /class/synthetic-colloid-plasma-expander.

What development phase is Tetraspan, B. Braun, Melsungen, Germany in?

Tetraspan, B. Braun, Melsungen, Germany is FDA-approved (marketed).

What are the side effects of Tetraspan, B. Braun, Melsungen, Germany?

Common side effects of Tetraspan, B. Braun, Melsungen, Germany include Coagulopathy / increased bleeding risk, Acute kidney injury, Hyperchloremic acidosis, Allergic reactions.

Related